Brest University hospital
Morlaix, 29672, France
NCT Number: NCT02555202
The main objective of this study is to develop and to validate a French version of the London Chest Activity of Daily Living (LCADL) and the Dyspnea 12 and to determine the reliability of this version for the evaluation of the dyspnea in the Activity of Daily Living in COPD patients (stages severe and very severe).
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Morlaix, 29672, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 15 days
by comparison with item activities of the Saint-Georges questionnaire for the LCADL
Time frame: 15 days
by comparison with MMRC dyspnea scale for the dyspnea 12
University Hospital, Brest
Other
Validation of the French Version of the London Chest Activity of Daily Living Scale (LCADL) and the Dyspnea-12 Questionnaire
Acronym: LCADL
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05412160
Amino Acid Metabolism, Inborn Errors, Argininemia
Milan, Italy
View Trial DetailsNCT04997200
COPD, Chronic Disease
Karlskrona, Blekinge County, Sweden
View Trial DetailsNCT03442140
COPD, Chronic Disease
Dallas, Texas, United States
View Trial DetailsNCT04868357
Anxiety, Anxiety Disorders
Briis-sous-Forges, France
View Trial Details